The study received logistic supports from Malaria and Bilharzia in Southern Africa(MABISA)project under which the study was conducted,funded by Wold Health Organisation(WHO)Special Programme for Research and Training in Tropical Diseases(TDR)and the Canadian International Development Research Centre(IDRC);The study was also supported by the College of Health Sciences scholarship program at the University of KwaZulu-Natal.
Background:Despite its low cure rates and possible resistance,praziquantel(PZQ)is the only drug available for schistosomiasis treatment.Hence,monitoring its efficacy is crucial.This study assessed the efficacy of PZQ,...